Public-private Collaborations and Partnerships in Stratified Medicine

Making Sense of New Interactions

Published in: New Biotechnology, v. 29, no. 6, Sep. 2012, p. 732-740

Posted on RAND.org on September 01, 2012

by Joanna Chataway, Caroline Viola Fry, Sonja Marjanovic, Ohid Yaqub

Read More

Access further information on this document at New Biotechnology

This article was published outside of RAND. The full text of the article can be found at the link above.

The field of personalised or stratified medicine is evolving alongside the formation of a plethora of public-private partnerships. Such collaborations are at the core of the set of new life sciences policies in the UK, but the rationale and basis for collaboration remains unclear and there is little indication in policy documents of clear boundaries for them. An article in the journal New Biotechnology discusses some of the drivers and dynamics of these collaborations.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.